Skip to main content
  • Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment.  Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 9, 2011

 

Drug Name

Review Type Class Manufacturer
Pradaxa New Drug Initial Review Direct Thrombin Inhibitor Boehringer Ingelheim
Veregen New Drug Initial Review Topical Genital Wart � HPV Treatment Agent PharmaDerm
Latuda New Drug Initial Review Antipsychotic Sunovion
Kapvay New Drug Initial Review Alpha-2 Adrenergic Agent Shionogi Pharma
Fanapt New Drug Appeal Atypical Antipsychotic Novartis
Pegasys PDL Appeal Hepatitis B and C Agent Genentech